<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03339830</url>
  </required_header>
  <id_info>
    <org_study_id>IO-SMA-Registry</org_study_id>
    <secondary_id>2017-A02291-52</secondary_id>
    <nct_id>NCT03339830</nct_id>
  </id_info>
  <brief_title>European Registry of Patients With Infantile-onset Spinal Muscular Atrophy</brief_title>
  <official_title>European Registry of Patients With Infantile-onset Spinal Muscular Atrophy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut de Myologie, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut de Myologie, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      IO-SMA-Registry is a prospective, longitudinal and observational study which objective is to
      collect prospectively information on longevity, psychomotor development and respiratory
      function of patients with infantile-onset spinal muscular atrophy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 10, 2017</start_date>
  <completion_date type="Anticipated">December 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Change from Baseline in survival</measure>
    <time_frame>Baseline and then every 6 months until the end of the study, up to 5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline in psychomotor development</measure>
    <time_frame>Baseline and then every 6 months until the end of the study, up to 5 years</time_frame>
    <description>Motor milestones acquired and/or lost</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline in the number of lower track infections</measure>
    <time_frame>Baseline and then every 6 months until the end of the study, up to 5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline in ventilation use</measure>
    <time_frame>Baseline and then every 6 months until the end of the study, up to 5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline in cough assist use</measure>
    <time_frame>Baseline and then every 6 months until the end of the study, up to 5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline in Forced Vital Capacity</measure>
    <time_frame>Baseline and then every 6 months until the end of the study, up to 5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline in diurnal saturation</measure>
    <time_frame>Baseline and then every 6 months until the end of the study, up to 5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline in nocturnal hypercapnia</measure>
    <time_frame>Baseline and then every 6 months until the end of the study, up to 5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from the beginning of the treatment of psychomotor development</measure>
    <time_frame>Since the beginning of the treatment until the end of the study, up to 5 years</time_frame>
    <description>Retrospective and prospective collection of data from patients/parents interview and medical files Motor milestones acquired and/or lost</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from the beginning of the treatment of the number of hospitalizations</measure>
    <time_frame>Since the beginning of the treatment until the end of the study, up to 5 years</time_frame>
    <description>Retrospective and prospective collection of data from patients/parents interview and medical files</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from the beginning of the treatment of the duration of hospitalizations</measure>
    <time_frame>Since the beginning of the treatment until the end of the study, up to 5 years</time_frame>
    <description>Retrospective and prospective collection of data from patients/parents interview and medical files</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline of Clinical Global Impressions - Improvement (CGI-I)</measure>
    <time_frame>Baseline and then every 6 months until the end of the study, up to 5 years</time_frame>
    <description>Quantification of patient progress and treatment response over time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline of the scoliosis occurence</measure>
    <time_frame>Baseline and then every 6 months until the end of the study, up to 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline of the arthrodesis occurence</measure>
    <time_frame>Baseline and then every 6 months until the end of the study, up to 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline of contractures occurrence</measure>
    <time_frame>Baseline and then every 6 months until the end of the study, up to 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline of wheelchair use</measure>
    <time_frame>Baseline and then every 6 months until the end of the study, up to 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline of feeding status</measure>
    <time_frame>Baseline and then every 6 months until the end of the study, up to 5 years</time_frame>
    <description>Feeding difficulties (swallowing, chewing, sucking), excessive drooling, need of a feeding tube, occurrence of gastrostomy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline of speech impairment</measure>
    <time_frame>Baseline and then every 6 months until the end of the study, up to 5 years</time_frame>
    <description>Speech incapacity, voice tone disorders</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline of Hammersmith Infant Neurological Examination (HINE) score</measure>
    <time_frame>Baseline and then every 6 months until the end of the study, up to 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline of Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP-INTEND) score</measure>
    <time_frame>Baseline and then every 6 months until the end of the study, up to 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline of Motor Function Measure (MFM) score</measure>
    <time_frame>Baseline and then every 6 months until the end of the study, up to 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline of Expanded Hammersmith Functional Motor Scale (HFMSE) score</measure>
    <time_frame>Baseline and then every 6 months until the end of the study, up to 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline of the number of physiotherapy sessions per week</measure>
    <time_frame>Baseline and then every 6 months until the end of the study, up to 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline of the number of balneotherapy sessions per week</measure>
    <time_frame>Baseline and then every 6 months until the end of the study, up to 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline of the number of occupational therapy sessions per week</measure>
    <time_frame>Baseline and then every 6 months until the end of the study, up to 5 years</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Spinal Muscular Atrophy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Neuromuscular reference centers
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Spinal Muscular Atrophy diagnosed in childhood (before 18 months) and genetically
             confirmed.

          -  For patients with SMA type 1: Never acquired independent sitting position (more than
             30 seconds, without hand support or any external support)

          -  For patients with SMA type 2 or 3: Patient treated with a market approved treatment
             for SMA or with a treatment in an expanded access program

          -  Any age

          -  Patients over 18 years of age or parent(s)/legal guardian(s) of patients &lt; 18 years of
             age not opposed to data collection for research purposes

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laurent Servais, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Myology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mélanie Annoussamy, PhD</last_name>
    <phone>+33171738393</phone>
    <email>m.annoussamy@institut-myologie.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hopital Morvan - CHU de Brest</name>
      <address>
        <city>Brest</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juliette Ropars, M.D.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Service de Rééducation Pédiatrique Infantile &quot; L'Escale &quot; - Hôpital Femme Mère Enfant</name>
      <address>
        <city>Bron</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carole Vuillerot, M.D.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital le Bocage - CHU Dijon</name>
      <address>
        <city>Dijon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mondher Chouchane, M.D.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Maladie Neuromusculaire de l'enfant - Service Maladies infectieuses et neurologie infantile - Hôpital Roger Salengro</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Marie Cuisset, M.D.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>I-Motion Institute</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karolina Aragon, MD</last_name>
      <email>k.aragon@institut-myologie.org</email>
    </contact>
    <contact_backup>
      <last_name>Ilhan Said Ali</last_name>
      <email>i.said-ali@institut-myologie.org</email>
    </contact_backup>
    <investigator>
      <last_name>Laurent Servais, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Unité de neurologie pédiatrique - Hôpital des enfants</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claude Cances, M.D.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 18, 2017</study_first_submitted>
  <study_first_submitted_qc>November 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 13, 2017</study_first_posted>
  <last_update_submitted>January 23, 2018</last_update_submitted>
  <last_update_submitted_qc>January 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>SMA</keyword>
  <keyword>Spinal Muscular Atrophy</keyword>
  <keyword>Neuromuscular disease</keyword>
  <keyword>Spinraza</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrophy</mesh_term>
    <mesh_term>Muscular Atrophy</mesh_term>
    <mesh_term>Muscular Atrophy, Spinal</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

